[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343132-105":59,"doc-detail-343132-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","metabolic-fingerprinting-of-serum-and-seminal-plasma-of-testicular-cancer-patients-using-raman-spectroscopy-a-pilot-study","Metabolic Fingerprinting of Serum and Seminal Plasma of Testicular Cancer Patients Using Raman Spectroscopy - A Pilot Study","","Metabolic fingerprinting aims to improve early detection of testicular cancer, where diagnosis remains difficult despite the availability of metabolomics. A pilot study analyzed serum and seminal plasma metabolomes from testicular cancer patients and fertile controls using Raman spectroscopy. Principal component and functional group analyses evaluated group separation, showing limited discrimination in serum but significant differences in seminal plasma. Functional group shifts supported candidate biomarker exploration for faster screening.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/metabolic-fingerprinting-of-serum-and-seminal-plasma-of-testicular-cancer-patients-using-raman-spectroscopy-a-pilot-study/343132/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/metabolic-fingerprinting-of-serum-and-seminal-plasma-of-testicular-cancer-patients-using-raman-spectroscopy-a-pilot-study/343132.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this pilot study?","Question",{"text":112,"@type":113},"To identify potential biomarkers for testicular cancer using a metabolic fingerprinting approach applied to serum and seminal plasma with Raman spectroscopy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many participants were included, and what were the groups?",{"text":117,"@type":113},"The study included 9 testicular cancer patients and 10 controls (fertile men) for comparative metabolomic analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show for serum versus seminal plasma?",{"text":121,"@type":113},"Serum samples did not show possible differentiation between healthy men and patients, while seminal plasma showed a significant difference between groups (p\u003C0.05).",{"name":123,"@type":110,"acceptedAnswer":124},"Which biomarker signals were highlighted?",{"text":125,"@type":113},"Functional group analysis suggested increased tryptophan concentration ratio in serum and broader increases across several compounds in seminal plasma, with phenylalanine noted as particularly relevant.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},343132,1790171160,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Metabolic Fingerprinting of Serum and Seminal Plasma of Testicular Cancer Patients Using Raman Spectroscopy: A Pilot Study  \nNiknam Lakpour 1, 2†, Mohammad Reza Sadeghi 3†, Naser Jafarzadeh 4, Ralf Henkel 5, 6, 7, Azadeh Hajiparvaneh 8, Zohreh Fathi 8, Roya Ghods 1, 9􀀍 , Kambiz Gilany 10􀀍 , Zahra Madjd 1, 9􀀍  \n1-Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran  \n2-Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran 3-Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran  \n4-Department of Medical Physics, Tarbiat Modares University, Tehran, Iran  \n5-Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK 6-Department of Medical Bioscience, University of the Western Cape, Bellville, South Africa  \n7-LogixX Pharma, Theale, Berkshire, UK  \n8-Avicenna Fertility Center, Avicenna Research Institute, ACECR, Tehran, Iran  \n9-Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran 10-Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran  \n† The first and the second authors have had equal contribution to this manuscript  \n* Corresponding Authors: Zahra Madjd, Oncopathology Research Center, Department of Molecular Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran  \nKambiz Gilany, Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran  \nRoya Ghods, Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran  \nE-mail: [majdjabari.z@iums.ac.ir](majdjabari.z@iums.ac.ir), [Zahra.madjd@yahoo.com](Zahra.madjd@yahoo.com), [k.gilany@avicenna.ac.ir](k.gilany@avicenna.ac.ir), [ghods.ro@iums.ac.ir](ghods.ro@iums.ac.ir), [rghods77@yahoo.com](rghods77@yahoo.com)  \n[Received:](Received: 1)[ 1](Received: 1), Jan. 2024  \nAccepted: 13, Mar. 2024  \nAbstract  \nBackground: Testicular cancer (TC) is a relatively rare type of cancer in men. Early diagnosis of TC remains challenging. Metabolomics holds promise in offering valuable insights in this regard. In this study, a metabolic fingerprinting approach was employed to identify potential biomarkers in both serum and seminal plasma of TC patients.  \nMethods: A total of 9 patients with testicular cancer and 10 controls were included in the study. The metabolic fingerprinting approach was utilized as a rapid diagnostic tool to analyze the metabolome in serum and seminal plasma of TC patients in comparison to fertile men. Raman spectroscopy was applied for the analysis of metabolites in these biological samples.  \nResults: Principal component analysis (PCA) and functional group analysis showed that the differentiation between serum samples from healthy men and TC patients was not possible. However, when analyzing seminal plasma, a significant difference was found between the two groups (p\u003C0.05) . Functional group analysis of serum only showed an increase in tryptophan concentration ratio in TC patients as compared to healthy men (p=0.03) . In contrast, in seminal plasma of TC patients, this increase was observed in all analyzed compounds, including phenylalanine, tyrosine, lipids, proteins, phenols (p\u003C0.001) .  \nConclusion: Our study highlights the potential of metabolic fingerprinting as a fast diagnostic tool for screening TC patients, with seminal plasma serving as a valuable biological sample. Furthermore, several potential biomarkers, particularly phenylalanine, were identified in seminal plasma. This research contributes to our understanding ofTC pathogenesis and has the potential to pave the way for early detection and personalized treatment approaches.  \nKeywords: Metabolic fingerprinting, Raman spectroscopy, Seminal plasma, Serum, Testicular cancer.  \nTo cite this article: Lakpour N, Sadeghi MR, Jafarzadeh N, Henkel R, Hajiparvaneh A, Fathi Z, et al.","cbCainBBj9amIKwm","https://ap.wps.com/l/cbCainBBj9amIKwm","pdf",636635,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Keywords","[{\"question\":\"What is the main goal of this pilot study?\",\"answer\":\"To identify potential biomarkers for testicular cancer using a metabolic fingerprinting approach applied to serum and seminal plasma with Raman spectroscopy.\"},{\"question\":\"How many participants were included, and what were the groups?\",\"answer\":\"The study included 9 testicular cancer patients and 10 controls (fertile men) for comparative metabolomic analysis.\"},{\"question\":\"What did the results show for serum versus seminal plasma?\",\"answer\":\"Serum samples did not show possible differentiation between healthy men and patients, while seminal plasma showed a significant difference between groups (p\\u003c0.05).\"},{\"question\":\"Which biomarker signals were highlighted?\",\"answer\":\"Functional group analysis suggested increased tryptophan concentration ratio in serum and broader increases across several compounds in seminal plasma, with phenylalanine noted as particularly relevant.\"}]","Metabolic Fingerprinting of Serum and Seminal Plasma of Testicular Cancer Patients Using Raman Spectroscopy - A Pilot Study | PDF",1790050041,23,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93b070d026df1498322a8b1438998463.webp",983,1390,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/287ff0e3d01a917e16c981cc6a34860a.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2926328be4a2c2b382324f78044357d.webp",981,1387,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/837c9299695a38039deac355f9247fc7.webp",980,1385]